[DPHARMA] QoQ Annualized Quarter Result on 31-Dec-2012 [#4]

Announcement Date
25-Feb-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Dec-2012 [#4]
Profit Trend
QoQ- -2.53%
YoY- -2.59%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Revenue 155,561 151,652 151,348 135,310 133,242 140,824 144,228 5.16%
PBT 41,356 43,926 35,824 35,298 35,064 35,812 35,476 10.75%
Tax -9,122 -9,150 -9,028 -9,284 -8,374 -8,662 -8,644 3.65%
NP 32,233 34,776 26,796 26,014 26,689 27,150 26,832 12.99%
-
NP to SH 32,233 34,776 26,796 26,014 26,689 27,150 26,832 12.99%
-
Tax Rate 22.06% 20.83% 25.20% 26.30% 23.88% 24.19% 24.37% -
Total Cost 123,328 116,876 124,552 109,296 106,553 113,674 117,396 3.33%
-
Net Worth 179,125 187,340 176,143 169,354 167,965 162,400 170,824 3.21%
Dividend
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Div - 11,101 - 19,434 - 9,716 - -
Div Payout % - 31.92% - 74.71% - 35.79% - -
Equity
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Net Worth 179,125 187,340 176,143 169,354 167,965 162,400 170,824 3.21%
NOSH 138,856 138,770 138,695 138,815 138,814 138,803 138,881 -0.01%
Ratio Analysis
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
NP Margin 20.72% 22.93% 17.70% 19.23% 20.03% 19.28% 18.60% -
ROE 17.99% 18.56% 15.21% 15.36% 15.89% 16.72% 15.71% -
Per Share
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 112.03 109.28 109.12 97.47 95.99 101.46 103.85 5.17%
EPS 23.21 25.06 19.32 18.74 19.23 19.56 19.32 12.99%
DPS 0.00 8.00 0.00 14.00 0.00 7.00 0.00 -
NAPS 1.29 1.35 1.27 1.22 1.21 1.17 1.23 3.22%
Adjusted Per Share Value based on latest NOSH - 138,819
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
RPS 16.17 15.77 15.73 14.07 13.85 14.64 14.99 5.17%
EPS 3.35 3.62 2.79 2.70 2.77 2.82 2.79 12.95%
DPS 0.00 1.15 0.00 2.02 0.00 1.01 0.00 -
NAPS 0.1862 0.1948 0.1831 0.1761 0.1746 0.1688 0.1776 3.19%
Price Multiplier on Financial Quarter End Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 -
Price 2.55 2.38 2.23 2.13 2.36 2.23 2.40 -
P/RPS 2.28 2.18 2.04 2.19 2.46 2.20 2.31 -0.86%
P/EPS 10.99 9.50 11.54 11.37 12.27 11.40 12.42 -7.82%
EY 9.10 10.53 8.66 8.80 8.15 8.77 8.05 8.50%
DY 0.00 3.36 0.00 6.57 0.00 3.14 0.00 -
P/NAPS 1.98 1.76 1.76 1.75 1.95 1.91 1.95 1.02%
Price Multiplier on Announcement Date
30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 CAGR
Date 19/11/13 28/08/13 27/05/13 25/02/13 23/11/12 16/08/12 17/05/12 -
Price 2.56 2.44 2.51 2.17 2.28 2.38 2.38 -
P/RPS 2.29 2.23 2.30 2.23 2.38 2.35 2.29 0.00%
P/EPS 11.03 9.74 12.99 11.58 11.86 12.17 12.32 -7.10%
EY 9.07 10.27 7.70 8.64 8.43 8.22 8.12 7.64%
DY 0.00 3.28 0.00 6.45 0.00 2.94 0.00 -
P/NAPS 1.98 1.81 1.98 1.78 1.88 2.03 1.93 1.71%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment